Edgestream Partners L.P. acquired a new position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) in the 3rd quarter, Holdings Channel.com reports. The firm acquired 33,375 shares of the company’s stock, valued at approximately $4,849,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. BlackRock Inc. acquired a new position in shares of Procter & Gamble during the 2nd quarter worth about $27,862,105,000. State Street Corp raised its holdings in Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after purchasing an additional 965,461 shares during the period. Bank of America Corp DE acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in Procter & Gamble during the 2nd quarter worth $2,281,505,000. Finally, Fisher Asset Management LLC lifted its holdings in Procter & Gamble by 7.5% during the third quarter. Fisher Asset Management LLC now owns 12,084,656 shares of the company’s stock worth $1,755,659,000 after acquiring an additional 845,717 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have commented on PG. Wells Fargo & Company raised their target price on shares of Procter & Gamble from $180.00 to $188.00 and gave the stock an “overweight” rating in a report on Wednesday. UBS Group set a $166.00 target price on Procter & Gamble in a report on Friday, October 23rd. The Goldman Sachs Group restated a “neutral” rating and issued a $161.00 price target on shares of Procter & Gamble in a report on Thursday, October 22nd. TD Cowen lifted their price objective on shares of Procter & Gamble from $150.00 to $166.00 and gave the company a “hold” rating in a report on Friday, October 23rd. Finally, Morgan Stanley increased their target price on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a report on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $170.95.
Read Our Latest Stock Analysis on PG
Procter & Gamble Stock Performance
PG opened at $170.25 on Thursday. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $173.59. The business has a 50 day moving average of $155.87 and a 200-day moving average of $150.25. The stock has a market cap of $394.61 billion, a price-to-earnings ratio of 25.64, a PEG ratio of 4.22 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. During the same quarter in the prior year, the business earned $1.99 EPS. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. On average, equities research analysts expect that Procter & Gamble Company will post 6.99 earnings per share for the current year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, November 16th. Investors of record on Friday, October 23rd were paid a $1.0885 dividend. The ex-dividend date was Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.6%. Procter & Gamble’s payout ratio is 65.51%.
Latest Procter & Gamble News
Investors following PG have been watching these news items:
- Positive Sentiment: P&G’s Health Care segment may have room to extend sales momentum, supported by improving cold-and-cough demand, product innovation and the Thorne acquisition. Read More.
- Positive Sentiment: Commentary highlights P&G’s long dividend-increase record and free-cash-flow support for its payout, reinforcing its appeal to investors seeking dependable income. Read More.
- Neutral Sentiment: Recent retirement-income coverage includes P&G among established dividend stocks. These list-based recommendations may support its defensive reputation, but offer limited company-specific news. Read More.
Insider Activity
In other news, CEO Shailesh Jejurikar sold 35,000 shares of Procter & Gamble stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the sale, the chief executive officer owned 55,391 shares of the company’s stock, valued at approximately $9,033,718.19. This trade represents a 38.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Matthew Janzaruk sold 9,479 shares of the company’s stock in a transaction dated Tuesday, November 3rd. The shares were sold at an average price of $163.00, for a total transaction of $1,545,077.00. Following the completion of the transaction, the chief accounting officer owned 1,271 shares in the company, valued at $207,173. This trade represents a 88.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 193,738 shares of company stock worth $31,813,782. Corporate insiders own 0.23% of the company’s stock.
Procter & Gamble Company Profile
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
